|
USP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.196500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.25649999999944E-05 |
| Normal-vs-Stage2 |
2.755400E-01 |
| Normal-vs-Stage3 |
7.169600E-02 |
| Normal-vs-Stage4 |
1.241980E-02 |
| Stage1-vs-Stage2 |
9.883900E-02 |
| Stage1-vs-Stage3 |
5.463900E-02 |
| Stage1-vs-Stage4 |
4.468400E-01 |
| Stage2-vs-Stage3 |
8.095800E-01 |
| Stage2-vs-Stage4 |
3.752400E-01 |
| Stage3-vs-Stage4 |
4.190600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.423700E-04 |
| Normal-vs-AfricanAmerican |
5.947700E-02 |
| Normal-vs-Asian |
5.797600E-04 |
| Caucasian-vs-AfricanAmerican |
6.166600E-01 |
| Caucasian-vs-Asian |
2.505200E-01 |
| AfricanAmerican-vs-Asian |
7.723800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.543000E-03 |
| Normal-vs-Female |
3.024600E-04 |
| Male-vs-Female |
5.781000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.51041999999491E-05 |
| Normal-vs-Age(41-60Yrs) |
5.421300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.341600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.232200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.601700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.816200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.461640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.781960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.132800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.414800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.070380E-01 |
| Classical-VS-Follicular |
2.54440002400713E-09 |
| Classical-VS-Other |
1.827550E-01 |
| Classical-VS-Normal |
3.07039999980496E-07 |
| Tall-VS-Follicular |
4.429800E-02 |
| Tall-VS-Other |
6.254400E-01 |
| Tall-VS-Normal |
8.404200E-02 |
| Follicular-VS-Other |
5.402000E-01 |
| Follicular-VS-Normal |
4.556400E-01 |
| Other-VS-Normal |
6.683800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.911500E-02 |
| Normal-vs-N1 |
1.213030E-01 |
| N0-vs-N1 |
9.013600E-01 |
|
|
